APA

Wu L., Yu J., Chen R., Liu Y., Lou L., Wu Y., Huang L., Fan Y., Gao P., Huang M., Wu Y., Chen Y. & Xu J. (20151209). Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Wu Lixian, Yu Jing, Chen Ruijia, Liu Yang, Lou Liguang, Wu Ying, Huang Lisen, Fan Yingjuan, Gao Pinzhang, Huang Meijuan, Wu Yong, Chen Yuanzhong and Xu Jianhua. 20151209. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Wu L., Yu J., Chen R., Liu Y., Lou L., Wu Y., Huang L., Fan Y., Gao P., Huang M., Wu Y., Chen Y. and Xu J. (20151209). Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Wu Lixian, Yu Jing, Chen Ruijia, Liu Yang, Lou Liguang, Wu Ying, Huang Lisen, Fan Yingjuan, Gao Pinzhang, Huang Meijuan, Wu Yong, Chen Yuanzhong and Xu Jianhua. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20151209.